Nitroglycerin 2.6 mg Controlled Release (CR) tablets are formulated to provide sustained anti-anginal action for the prevention of chest pain (angina pectoris). Nitroglycerin belongs to the nitrate class of vasodilators that works by relaxing blood vessels, improving blood flow to the heart muscle, and reducing cardiac workload. The controlled-release formulation ensures gradual and prolonged release of Nitroglycerin, helping maintain steady plasma levels and providing extended protection against angina attacks. It is commonly prescribed in patients with stable angina, coronary artery disease, and other ischemic heart conditions. This medication helps reduce the frequency and severity of angina episodes and improves exercise tolerance in patients with cardiovascular disease.
